share_log

新銳醫藥：主要交易 －收購目標公司16%已發行股本及股東特別大會通告

NEW RAY MEDIC: MAJOR TRANSACTION -ACQUISITION OF 16% OF THE ISSUED SHARE CAPITALOF THE TARGET COMPANYANDNOTICE OF SPECIAL GENERAL MEETING

Hong Kong Stock Exchange ·  Jun 21 20:38
Summary by Futu AI
新銳醫藥國際控股有限公司（「本公司」）宣布，將於二零二四年七月十六日舉行股東特別大會，以考慮及通過收購中國女媧醫藥集團股份有限公司16%股權的買賣協議。該協議由本公司間接全資附屬公司Major Bright Holdings Limited與賣方于文勇先生於二零二四年五月十六日簽訂，收購代價為17,280,000港元。收購完成後，本公司將持有目標公司16%股權。此外，本公司亦公布了與此次收購相關的未經審核備考財務資料及獨立估值報告。股東特別大會將於香港中環德輔道中19號環球大廈12樓1203B、1204–1205室舉行。
新銳醫藥國際控股有限公司（「本公司」）宣布，將於二零二四年七月十六日舉行股東特別大會，以考慮及通過收購中國女媧醫藥集團股份有限公司16%股權的買賣協議。該協議由本公司間接全資附屬公司Major Bright Holdings Limited與賣方于文勇先生於二零二四年五月十六日簽訂，收購代價為17,280,000港元。收購完成後，本公司將持有目標公司16%股權。此外，本公司亦公布了與此次收購相關的未經審核備考財務資料及獨立估值報告。股東特別大會將於香港中環德輔道中19號環球大廈12樓1203B、1204–1205室舉行。
New Ray Medic International Holdings Limited (the "Company") announces that a special meeting of shareholders will be held on July 16, 2024 to consider and approve the acquisition agreement for the purchase of 16% equity interest in China Nvai Pharmaceutical Group Co., Ltd. The agreement was signed on May 16, 2024 between the Company's wholly-owned subsidiary, Major Bright Holdings Limited, and the seller, Mr. Yu Wen Yong, for a purchase price of HKD 17,280,000. After the completion of the acquisition, the Company will hold 16% equity interest in the target company. In addition, the Company has also disclosed unaudited financial information and an independent valuation report related to the acquisition. The special meeting of shareholders will be held at Rooms 1203B, 1204-1205, 12/F, World-wide House, 19 Des Voeux Road Central, Hong Kong.
New Ray Medic International Holdings Limited (the "Company") announces that a special meeting of shareholders will be held on July 16, 2024 to consider and approve the acquisition agreement for the purchase of 16% equity interest in China Nvai Pharmaceutical Group Co., Ltd. The agreement was signed on May 16, 2024 between the Company's wholly-owned subsidiary, Major Bright Holdings Limited, and the seller, Mr. Yu Wen Yong, for a purchase price of HKD 17,280,000. After the completion of the acquisition, the Company will hold 16% equity interest in the target company. In addition, the Company has also disclosed unaudited financial information and an independent valuation report related to the acquisition. The special meeting of shareholders will be held at Rooms 1203B, 1204-1205, 12/F, World-wide House, 19 Des Voeux Road Central, Hong Kong.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.